Translational research approach to biological and modifiable risk factors of psychosis and affective disorders

World Journal of Biological Psychiatry

Volumn 12, Issue SUPPL. 1, 2011, Pages 28-34

  Baune, B T ^a   Thome, J ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Comorbidity; Depression; Environment; Epidemiology; Genes; Neuroscience; Schizophrenia; Translational psychiatry

Indexed keywords

BIOLOGICAL FACTOR; CLOZAPINE;

CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMORBIDITY; DISEASE COURSE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE INTERACTION; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGE FACTORS; BRAIN; COMORBIDITY; COOPERATIVE BEHAVIOR; DEPRESSIVE DISORDER, MAJOR; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MIDDLE AGED; MIND-BODY RELATIONS, METAPHYSICAL; PROGNOSIS; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; TRANSLATIONAL MEDICAL RESEARCH; YOUNG ADULT;

EID: 80052697974     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2011.603223     Document Type: Review

References (92)

1. Alvarenga ME, Caniato RN, Mauritz A, Braun A, Aljeesh Y, Baune BT. 2009. Health service utilization in patients with major depression and co-morbid pain. Psychiatry Clin Neuro-sci 63:101-106.
2. Arolt V, Fein A, Driessen M, Dorlochter L, Maintz C. 1998. Depression and social functioning in general hospital in-patients. J Psychosom Res 45:117-126. (Pubitemid 28403197)
3. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. 2002. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Br Med J 325: 1212-1213. (Pubitemid 35398785)
4. Aslund C, Leppert J, Comasco E, Nordquist N, Oreland L, Nilsson KW. 2009. Impact of the interaction between the 5HTTLPR polymorphism and maltreatment on adolescent depression. A population-based study. Behav Genet 39:524-531.
5. Baune BT, Aljeesh Y. 2006. The association of psychological stress and health related quality of life among patients with stroke and hypertension in Gaza Strip. Ann Gen Psychiatry 5:6.
6. Baune BT, Adrian I, Arolt V, Berger K. 2006. Associations between major depression, bipolar disorders, dysthymia and cardiovascular diseases in the general adult population. Psy-chother Psychosom 75:319-326. (Pubitemid 44200480)
7. Baune BT, Adrian I, Jacobi F. 2007. Medical disorders affect health outcome and general functioning depending on comor-bid major depression in the general population. J Psychosom Res 62:109-118. (Pubitemid 46161593)
8. Baune BT, Caniato RN, Arolt V, Berger K. 2009a. The effects of dysthymic disorder on health-related quality of life and disability days in persons with comorbid medical conditions in the general population. Psychother Psychosom 78:161-166.
9. Baune BT, McAfoose J, Leach G, Quirk F, Mitchell D. 2009b. Impact of psychiatric and medical comorbidity on cognitive function in depression. Psychiatry Clin Neurosci 63:392-400.
10. Beardslee WR, Versage EM, Gladstone TR. 1998. Children of affectively ill parents: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 37:1134-1141.
11. Bebbington PE, Bhugra D, Brugha T, Singleton N, Farrell M, Jenkins R, et al. 2004. Psychosis, victimisation and childhood disadvantage: evidence from the second British National Survey of Psychiatric Morbidity. Br J Psychiatry 185:220-6. (Pubitemid 39208223)
12. Beblo T, Sinnamon G, Baune BT. 2011. Specifying the neu-ropsychology of affective disorders: clinical, demographic and neurobiological factors. Neuropsychol Rev Jun 10. [Epub ahead of print].
13. Berto P, D'Ilario D, Ruffo P, Di Virgilio R, Rizzo F. 2000. Depression: cost-of-illness studies in the international literature, a review. J Ment Health Policy Econ 3:3-10.
14. Booth BM, Zhang M, Rost KM, Clardy JA, Smith LG, Smith GR. 1997. Measuring outcomes and costs for major depression. Psychopharmacol Bull 33:653-658. (Pubitemid 28128118)
15. Brown AS. 2011. The environment and susceptibility to schizophrenia. Prog Neurobiol 93:23-58.
16. Brown AS, Derkits EJ. 2010. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167:261-280.
17. Brown S, Inskip H, Barraclough B. 2000. Causes of the excess mortality of schizophrenia. Br J Psychiatry 177:212-217.
18. Cantor-Graae E, Selten JP. 2005. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 162:12-24. (Pubitemid 40095666)
19. Carlson C, Hornbuckle K, DeLisle F, Kryzhanovskaya L, Breier A, Cavazzoni P. 2006. Diabetes mellitus and antipsychotic treatment in the United Kingdom. Eur Neuropsychopharma-col 16:366-375. (Pubitemid 43815731)
20. Caspi A, Moffitt TE. 2006. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 7:583-590. (Pubitemid 43995433)
21. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. 2003. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389. (Pubitemid 36877077)
22. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. 2010. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 167:509-527.
23. Colman I, Ataullahjan A. 2010. Life course perspectives on the epidemiology of depression. Can J Psychiatry 55:622-632.
24. Colman I, Ploubidis GB, Wadsworth ME, Jones PB, Croudace TJ. 2007. A longitudinal typology of symptoms of depression and anxiety over the life course. Biol Psychiatry 62:1265-1271. (Pubitemid 350060898)
25. Colman I, Croudace TJ, Wadsworth ME, Kuh D, Jones PB. 2008. Psychiatric outcomes 10 years after treatment with antidepres-sants or anxiolytics. Br J Psychiatry 193:327-331.
26. Degreef G, Bogerts B, Falkai P, Greve B, Lantos G, Ashtari M, Lieberman J. 1992. Increased prevalence of the cavum septum pellucidum in magnetic resonance scans and post-mortem brains of schizophrenic patients. Psychiatry Res 45:1-13.
27. DeLisi LE, Hoff AL, Kushner M, Degreef G. 1993. Increased prevalence of cavum septum pellucidum in schizophrenia. Psychiatry Res 50:193-199. (Pubitemid 23289195)
28. Dixon L, Weiden P, Delahanty J, Goldberg R, Postrado L, Lucksted A, Lehman A. 2000. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 26:903-912.
29. Dohrenwend BP, Levav I, Shrout PE, Schwartz S, Naveh G, Link BG, et al. 1992. Socioeconomic status and psychiatric disorders: the causation-selection issue. Science 255:946-952.
30. Eaton WW. 1985. Epidemiology of schizophrenia. Epidemiol Rev 7:105-126. (Pubitemid 15236003)
31. Fang J, Cheng Q. 2009. Etiological mechanisms of post-stroke depression: a review. Neurol Res 31:904-909.
32. Feinstein A. 2004. The neuropsychiatry of multiple sclerosis. Can J Psychiatry 49:157-163. (Pubitemid 38506493)
33. Felker B, Katon W, Hedrick SC, Rasmussen J, McKnight K, McDonnell MB, Fihn SD. 2001. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry 23:56-61. (Pubitemid 32335573)
34. Frasure-Smith N, Lesperance F. 2010. Depression and cardiac risk: present status and future directions. Heart 96:173-176.
35. Gale CR, Deary IJ, Boyle SH, Barefoot J, Mortensen LH, Batty GD. 2008. Cognitive ability in early adulthood and risk of 5 specific psychiatric disorders in middle age: the Vietnam experience study. Arch Gen Psychiatry 65:1410-1418.
36. Gendelman N, Snell-Bergeon JK, McFann K, Kinney G, Paul Wadwa R, Bishop F, et al. 2009. Prevalence and correlates of depression in individuals with and without type 1 diabetes. Diabetes Care 32:575-579.
37. Gilman SE, Kawachi I, Fitzmaurice GM, Buka SL. 2002. Socio-economic status in childhood and the lifetime risk of major depression. Int J Epidemiol 31:359-367. (Pubitemid 34537793)
38. Goodyer IM, Bacon A, Ban M, Croudace T, Herbert J. 2009. Serotonin transporter genotype, morning cortisol and subsequent depression in adolescents. Br J Psychiatry 195:39-45.
39. Gottesman II, Shields J. 1976. A critical review of recent adoption, twin, and family studies of schizophrenia: behavioral genetics perspectives. Schizophr Bull 2:360-401. (Pubitemid 8002656)
40. Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ, et al. 2005. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry 10:220-224. (Pubitemid 40188517)
41. Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, Corey-Lisle PK. 2003. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 64:1465-1475. (Pubitemid 41270106)
42. Horwood LJ, Fergusson DM. 1986. Neuroticism, depression and life events: a structural equation model. Soc Psychiatry 21:63-71. (Pubitemid 16114038)
43. Hunkeler EM, Spector WD, Fireman B, Rice DP, Weisner C. 2003. Psychiatric symptoms, impaired function, and medical care costs in an HMO setting. Gen Hosp Psychiatry 25: 178-184. (Pubitemid 36555609)
44. Janssen I, Krabbendam L, Bak M, Hanssen M, Vollebergh W, de Graaf R, van Os J. 2004. Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatr Scand 109:38-45. (Pubitemid 38161099)
45. Jones DR, Macias C, Barreira PJ, Fisher WH, Hargreaves WA, Harding CM. 2004. Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatr Serv 55:1250-1257. (Pubitemid 39441587)
46. Katon W, Russo J, Lin E, Heckbert S, Ciechanowski P, Ludman E, Korff M. 2009. Depression and diabetes: factors associated with major depression at five-year follow-up. Psychosomatics 50:570.
47. Katon WJ. 2003. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 54:216-226. (Pubitemid 37270614)
48. Katon WJ. 2011. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci 13:7-23.
49. Kendler KS, Gardner CO, Prescott CA. 2002. Toward a comprehensive developmental model for major depression in women. Am J Psychiatry 159:1133-1145. (Pubitemid 34743253)
50. Kendler KS, Gardner CO, Prescott CA. 2006. Toward a comprehensive developmental model for major depression in men. Am J Psychiatry 163:115-124. (Pubitemid 43050112)
51. Kirkbride JB, Fearon P, Morgan C, Dazzan P, Morgan K, Tarrant J, et al. 2006. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry 63:250-258. (Pubitemid 43345348)
52. Kornegay CJ, Vasilakis-Scaramozza C, Jick H. 2002. Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database. J Clin Psychiatry 63:758-762.
53. Krieger N. 1994. Epidemiology and the web of causation: has anyone seen the spider? Soc Sci Med 39:887-903. (Pubitemid 24264502)
54. Kwon JS, Shenton ME, Hirayasu Y, Salisbury DF, Fischer IA, Dickey CC, et al. 1998. MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder. Am J Psychiatry 155:509-515. (Pubitemid 28207447)
55. Lamberti JS, Olson D, Crilly JF, Olivares T, Williams GC, Tu X, et al. 2006. Prevalence of the metabolic syndrome among patients receiving clozapine. Am J Psychiatry 163: 1273-1276. (Pubitemid 44464457)
56. Lawrie SM, Abukmeil SS. 1998. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 172: 110-120. (Pubitemid 28097708)
57. Leonhard B. 2007. Inflammation, depression and dementia: are they connected? Neurochem Res 32:1749-1756.
58. Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. 2007. Physical illness and schizophrenia. A review of the evidence. Cambridge: Cambridge University Press.
59. Levinson DF. 2006. The genetics of depression: a review. Biol Psychiatry 60:84-92.
60. Licinio J. 2010. The First International Conference on Transla-tional Medicine. Mol Psychiatry 15:878-879.
61. Licinio J. 2011. Translational psychiatry: leading the transition from the cesspool of devastation to a place where the grass is really greener. Transl Psychiatry 1 el; doi:10.1038/tp.2011.3; published online 4 April 2011.
62. Mancuso CA, Peterson MG, Charlson ME. 2000. Effects of depressive symptoms on health-related quality of life in asthma patients. J Gen Intern Med 15:301-310. (Pubitemid 30333827)
63. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. 2004. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2:13.
64. McMichael AJ. 1999. Prisoners of the proximate: loosening the constraints on epidemiology in an age of change. Am J Epidemiol 149:887-897. (Pubitemid 29230703)
65. Meyer JM, Nasrallah HA, McEvoy JP, Goff DC, Davis SM, Chakos M, et al. 2005. The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophr Res 80:9-18. (Pubitemid 41587459)
66. Meyer-Lindenberg A. 2010. From maps to mechanisms through neuroimaging of schizophrenia. Nature 468:194-202.
67. Musselman DL, Betan E, Larsen H, Phillips LS. 2003. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 54:317-329. (Pubitemid 37267861)
68. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. 1998. Hip-pocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 55:433-440. (Pubitemid 28237277)
69. Osborn DP, Nazareth I, King MB. 2006. Risk for coronary heart disease in people with severe mental illness: cross-sectional comparative study in primary care. Br J Psychiatry 188: 271-277. (Pubitemid 43341656)
70. Oud MJ, Meyboom-de Jong B. 2009. Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Fam Pract 10:32.
71. Paizanis E, Hamon M, Lanfumey L. 2007. Hippocampal neuro-genesis, depressive disorders, and antidepressant therapy. Neural Plast 2007:73754.
72. Pohle K, Domschke K, Roehrs T, Arolt V, Baune BT. 2009. Medical comorbidity affects antidepressant treatment response in patients with melancholic depression. Psychother Psycho-som 78:359-363.
73. Remington JS, Klein JO. 2006. Infectious diseases of the fetus and newborn infant. Philadelphia, PA: Elsevier Saunders.
74. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J, et al. 2009. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. J Am Med Assoc 301:2462-2471.
75. Sacchetti E, Turrina C, Parrinello G, Brignoli O, Stefanini G, Mazzaglia G. 2005. Incidence of diabetes in a general practice population: a database cohort study on the relationship with haloperidol, olanzapine, risperidone or quetiapine exposure. Int Clin Psychopharmacol 20:33-37. (Pubitemid 40105547)
76. Samele C, Patel M, Boydell J, Leese M, Wessely S, Murray R. 2007. Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Soc Psychiatry Psychiatr Epidemiol 42:117-124. (Pubitemid 46647112)
77. Shonkoff JP, Levitt P. 2010. Neuroscience and the future of early childhood policy: moving from why to what and how. Neuron 67:689-691.
78. Shonkoff JP, Boyce WT, McEwen BS. 2009. Neuroscience, molecular biology, and the childhood roots of health disparities: building a new framework for health promotion and disease prevention. J Am Med Assoc 301:2252-2259.
79. Smith GS, Gunning-Dixon FM, Lotrich FE, Taylor WD, Evans JD. 2007. Translational research in late-life mood disorders: implications for future intervention and prevention research. Neuropsychopharmacology 32:1857-1875. (Pubitemid 47258525)
80. Sotiropoulos I, Cerqueira JJ, Catania C, Takashima A, Sousa N, Almeida OF. 2008. Stress and glucocorticoid footprints in the brain-the path from depression to Alzheimer's disease. Neuro-sci Biobehav Rev 32:1161-1173.
81. Susser M. 1998. Does risk factor epidemiology put epidemiology at risk? Peering into the future. J Epidemiol Community Health 52:608-611. (Pubitemid 28464047)
82. Tandon R, Keshavan MS, Nasrallah HA. 2008. Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview. Schiz-ophr Res 100:4-19.
83. Taylor SE, Way BM, Welch WT, Hilmert CJ, Lehman BJ, Eisen-berger NI. 2006. Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol Psychiatry 60:671-676. (Pubitemid 44427767)
84. Thapar A, Harold G, Rice F, Langley K, O'Donovan M. 2007. The contribution of gene-environment interaction to psycho-pathology. Dev Psychopathol 19:989-1004.
85. Van Os J, Rutten BP, Poulton R. 2008. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull 34:1066-1082.
86. Van Winkel R, Esquivel G, Kenis G, Wichers M, Collip D, Peer-booms O, et al. 2010. Review: Genome-wide findings in schizophrenia and the role of gene-environment interplay. CNS Neurosci Ther 16:e185-192.
87. Vita A, De Peri L, Silenzi C, Dieci M. 2006. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 82: 75-88. (Pubitemid 43202650)
88. Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, et al. 2009. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 66:617-626.
89. Ward KE, Friedman L, Wise A, Schulz SC. 1996. Meta-analysis of brain and cranial size in schizophrenia. Schizophr Res 22:197-213. (Pubitemid 27019287)
90. WHO. 2011. Global burden of disease. WHO Health Statistics and Health Information Systems. Geneva, WHO.
91. Wilhelm K, Mitchell PB, Niven H, Finch A, Wedgwood L, Sci-mone A, et al. 2006. Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry 188:210-215. (Pubitemid 43341646)
92. Wuwongse S, Chang RC, Law AC. 2010. The putative neurode-generative links between depression and Alzheimer's disease. Prog Neurobiol 91:362-375.